Data / Form D filings / Pebble Labs Inc.
Pebble Labs Inc.: Form D filings
Pebble Labs Inc., a biotechnology company in Santa Fe, NM, filed 3 Form D notices with the SEC in 2019. The latest, on September 30, 2019, reports $3 million sold of a $3 million offering to 1 investor.
Find out what Pebble Labs Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 433 PASEO DE PERALTA, SUITE 200, Santa Fe, NM, 87501
- Phone
- (505) 577-2555
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1772371
The full lists. Form D filings in New Mexico: 56 rows, $5, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 30, 2019 | Amendment | $3,000,000 | $3,000,000 | $0 | 1 | Sep 25, 2019 | sec.gov |
| Sep 27, 2019 | New notice | $3,000,000 | $3,000,000 | $0 | 4 | Sep 25, 2019 | sec.gov |
| Sep 27, 2019 | New notice | $9,500,000 | $9,500,000 | $0 | 4 | Sep 24, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Thomas Smalley | Executive Officer, Director, Promoter | |
| Ronald E. Deutsch | Executive Officer | |
| Kimberly A. Landry | Executive Officer, Promoter | |
| Richard T. DeRose | Executive Officer | |
| Aristobulo T. Loaiza | Executive Officer | |
| Tichafa R. I. Munyikwa | Executive Officer | |
| Anne R. I. Lo | Executive Officer | |
| Paul M. Laur | Executive Officer | |
| Andrew T. Hunter | Executive Officer | |
| Pedro T. Costa-Nunes | Executive Officer | |
| Tatiana T. Vinogradova | Executive Officer | |
| Edward T. L. Cheung | Executive Officer, Promoter | |
| Jon M. Bloodworth | Executive Officer | |
| Tawanda T. Zidenga | Executive Officer | |
| Erick T. LeBrun | Executive Officer | |
| Michael Bruce Harrison | Executive Officer, Director, Promoter | |
| Richard Thomas Sayre | Executive Officer, Promoter |
Every Form D from the week of Sep 30, 2019 · All recent filings in New Mexico · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Pebble Labs Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.